Shilpa Medicare · NSE: SHILPAMED · BSE: 530549
Q4 FY22 results · Jan–Mar 2022
Shilpa Medicare reported revenue from operations of ₹340.60 crore (up 63.7% from Q4 FY21) and net profit of ₹29.55 crore (up 277.6% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 340.60 | 208.03 | +63.7% | 272.30 | +25.1% |
| Other income | 5.49 | 6.91 | −20.5% | 5.48 | +0.2% |
| Total income | 346.09 | 214.94 | +61.0% | 277.78 | +24.6% |
| Profit before tax | 46.40 | 8.40 | +452.2% | 20.00 | +132.0% |
| Net profit for the period | 29.55 | 7.83 | +277.6% | 9.54 | +209.9% |
| EPS, basic (₹) | 3.40 | 0.96 | +254.2% | 1.13 | +200.9% |
| Net margin (%) | 8.7 | 3.8 | 3.5 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 72.87 | 179.70 | −59.4% | 276.64 | −73.7% |
| Other income | 10.34 | 15.14 | −31.7% | 13.00 | −20.5% |
| Total income | 83.21 | 194.84 | −57.3% | 289.64 | −71.3% |
| Profit before tax | (3.33) | 35.22 | Turned loss | 48.34 | Turned loss |
| Net profit for the period | 35.45 | 26.59 | +33.3% | 36.77 | −3.6% |
| EPS, basic (₹) | 4.08 | 3.26 | +25.2% | 4.36 | −6.4% |
| Net margin (%) | 48.7 | 14.8 | 13.3 |
Consolidated
- Filed with BSE
- 24 May 2022, 16:43 IST
- Board meeting
- 23 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 May 2022, 16:43 IST
- Board meeting
- 23 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE